Crossmark

Portuguese recommendations for the management of transthyretin amyloid cardiomyopathy (Part 1 of 2): Screening, diagnosis and treatment. Developed by the Task Force on the management of transthyretin amyloid cardiomyopathy of the Working Group on Myocardial and Pericardial Diseases of the Portuguese Society of Cardiology

Crossref DOI link: https://doi.org/10.1016/j.repc.2024.11.009

Published Print: 2025-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Marques, Nuno

Aguiar Rosa, Sílvia

Cordeiro, Filipa

Menezes Fernandes, Raquel

Ferreira, Catarina

Bento, Dina

Brito, Dulce

Cardim, Nuno

Lopes, Luís

Azevedo, Olga
License Information

Text and Data Mining valid from 2025-02-01

Text and Data Mining valid from 2025-02-01

Version of Record valid from 2025-01-11
More Information

This article is maintained by: Elsevier

Article Title: Portuguese recommendations for the management of transthyretin amyloid cardiomyopathy (Part 1 of 2): Screening, diagnosis and treatment. Developed by the Task Force on the management of transthyretin amyloid cardiomyopathy of the Working Group on Myocardial and Pericardial Diseases of the Portuguese Society of Cardiology

Journal Title: Revista Portuguesa de Cardiologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repc.2024.11.009

Content Type: article

Copyright: © 2025 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below